Article
Effects of Specialized Pro-Resolving Mediators and Telerehabilitation on Fatigue, Dyspnea, and Quality of Life in Post‑COVID‑19 Condition: The ARACOV-02 Randomized Controlled Trial.
2026-06-10
Abstract excerpt
<title>Abstract</title> <p> <bold>Background:</bold> Post‑COVID‑19 Condition (PCC) is characterized by persistent multisystem symptoms, with fatigue and dyspnea among the most disabling. Specialized pro‑resolving mediators (SPMs) may modulate chronic inflammation, while telerehabilitation has emerged as an accessible therapeutic strategy. This randomized controlled trial (ARACOV‑02) evaluated the combined effec...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 988eaab3-5648-500c-bfc8-95ff4d307de9
- DOI
- 10.21203/rs.3.rs-9354365/v1
